Please use this identifier to cite or link to this item:
Type: Artigo
Title: HDL-Targeted therapies during myocardial infarction
Author: Sposito, Andrei C.
Carmo, Helison R.
Barreto, Joaquim
Sun, Lufan
Carvalho, Luiz Sergio F.
Feinstein, Steve B.
Zanotti, Ilaria
Kontush, Anatol
Remaley, Alan
Abstract: It is now apparent that a variety of deleterious mechanisms intrinsic to myocardial infarction (MI) exists and underlies its high residual lethality. Indeed, despite effective coronary patency therapies, ischemia and reperfusion (I/R) injury accounts for about 50% of the infarcted mass. In this context, recent studies in animal models have demonstrated that coronary reperfusion with high-density lipoproteins (HDL) may reduce MI size in up to 30%. A spectrum of mechanisms mediated by either HDL-related apolipoproteins or phospholipids attenuates myocardial cell death. Hence, promising therapeutic approaches such as infusion of reconstituted HDL particles, new HDL by genomic therapy, or the infusion of apoA-I mimetic peptides have been sought as a way of ensuring protection against I/R injury. In this review, we will explore the limitations and potential therapeutic effects of HDL therapies during the acute phase of MI
Subject: Traumatismo por reperfusão
Infarto do miocárdio
Country: Estados Unidos
Editor: Springer
Rights: Fechado
Identifier DOI: 10.1007/s10557-019-06865-1
Date Issue: 2019
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
000469352900012.pdf479.44 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.